FSH

FSH is often checked when periods stop before the usual menopause age, fertility stalls, or a low sperm count raises a testicular question. It answers one specific thing: is the problem in the ovaries or testicles themselves, or in the brain-pituitary signal that controls them?

That distinction changes what happens next. A high number points to the ovaries or testicles no longer answering the signal well. A low number points upstream, to the pituitary or hypothalamus. Same missed period, opposite workups.

What the Number Reflects

FSH stands for follicle-stimulating hormone. It is made by cells in the front of the pituitary gland, the small control hub under your brain. In women it helps ovarian follicles grow and make estrogen. In men it tells Sertoli cells in the testes to support sperm production.

The feedback loop is the useful part. When the ovaries or testicles stop answering, the pituitary shouts louder and FSH climbs. So a high level usually means the gonad is failing, not the pituitary. A low level means the signal from above has gone quiet. FSH reads out the brain-pituitary-gonad loop, and where you are in reproductive aging.

Reading FSH in Women: Eggs and Fertility

For fertility, timing matters. The usual reading is taken early in the cycle, on days two to four, and paired with estradiol. A rising early-cycle FSH is a specific but not sensitive sign of diminished ovarian reserve. If it is high, the ovary often responds weakly to stimulation; if it is normal, reserve can still be low.

FSH is a late marker. In one healthy-cycle study it rose by about one unit every nine years. AMH comes from the follicle pool itself, tends to fall before FSH rises, and can be measured on any cycle day. That is why FSH helps most when there is already an infertility or cycle question. In fertile women, ovarian reserve testing has no proven benefit and does not predict short-term chances of conceiving.

Menopause and Why the Number Jumps Around

FSH is high after menopause. Getting there is messy. Across the transition, FSH can swing from menopausal-looking ranges back down to fertile-looking ones within a cycle, and women can still ovulate after a reading that looked postmenopausal. It does not settle at a stable high level until about three to six years after the final period.

For women 45 or older with typical symptoms, guidelines advise diagnosing menopause from symptoms and bleeding pattern rather than from a single FSH. For women under 45, FSH can still help when early menopause or primary ovarian insufficiency is the question. Ethnicity matters too: African American women tend to run higher FSH through the transition than white, Chinese, or Japanese women.

Men: Sperm Production and Testicular Failure

In men FSH acts on the Sertoli cells that support sperm production. A high FSH alongside low testosterone points to the testicles themselves failing, from causes like Klinefelter syndrome, chemotherapy, radiation, or heavy alcohol use. A low or inappropriately normal FSH with low testosterone points upstream to the pituitary or hypothalamus.

On its own FSH is a poor predictor in men. Across the usual range its ability to flag a real sperm-production problem is weak, and it only becomes convincing at the extremes. So it is ordered with testosterone and luteinizing hormone, usually called LH, and read as a pattern rather than a single verdict.

Bone Loss and Hip Fracture

This is where high FSH has tracked a worse outcome in people. In a prospective study of older adults in Iceland, each standard-deviation step up in FSH came with about a fifth higher risk of breaking a hip after accounting for estrogen and testosterone. In postmenopausal women in the Women's Health Initiative, those in the top third for FSH had roughly three times the odds of low bone mass at the femoral neck, and about 1.7 times the odds at the total hip.

Cell and animal work, with some human cell evidence, suggests cells that break down bone have FSH receptors. That could let FSH speed bone breakdown directly, instead of just marking the estrogen loss around it. Either way, if your FSH is high and menopausal, bone density deserves attention.

The Heart and Metabolism Surprise

Now the turn. You might expect the high FSH of menopause to travel with more heart disease and diabetes. In postmenopausal women, the observational data mostly point the other way. Higher FSH tracked with lower predicted heart risk, with less thickening of the neck arteries, and with less diabetes. In one study women with the highest FSH were about half as likely to have diabetes; in another, women with the lowest FSH were roughly twice as likely to have prediabetes and about three times as likely to have diabetes.

One likely reason is body fat. More body fat tends to lower FSH, and more body fat raises metabolic and heart risk, so part of the link can come from who has the lower FSH to begin with. FSH is not a good-number or bad-number test. What a high level means depends on the question. Bone breaks one way, metabolism the other. In one large Danish study of men, FSH had no clear link to death from any cause.

Cancer Signals

In men, both unusually high and unusually low serum FSH years before diagnosis have been tied to later testicular germ cell tumors. An older study found the highest FSH group had roughly three times the risk of seminoma, the most common type. A larger, newer study found a U-shaped pattern instead, with both the lowest and highest FSH groups carrying about twice the risk. The links held after adjustment for sex hormones. In women, the ovarian cancer data do not support high FSH as a consistent risk signal. These are research findings, not reasons to order FSH as a cancer test.

Why One Reading Is Not Enough

How reliable a single FSH is depends on who you are. In men it is fairly steady; one study found within-person variation of about 8 percent, lower than the other reproductive hormones measured. In postmenopausal women, a single serum FSH also tracks the person reasonably well.

In premenopausal women, one reading is poor on its own. Repeated across cycles, the numbers scatter badly, and the scatter itself can matter: high cycle-to-cycle swing suggests more advanced decline in the egg pool. So the cadence follows your stage. Postmenopausal or male: one baseline, repeat if the clinical picture shifts. Premenopausal and assessing fertility: draw on days two to four with estradiol, and expect to confirm across more than one cycle before drawing conclusions.

When a Reading Can Fool You

• Cycle timing: in premenopausal women, this is the big one. FSH shifts through the cycle and peaks briefly around ovulation, so a reading taken on the wrong day can mislead completely. Days two to four is the window.
• Hormonal medications: birth control pills, estrogen therapy, fertility drugs, and testosterone can shift FSH without showing the baseline state of your ovaries or testicles.
• Body fat: more body fat tends to lower FSH, so a menopausal-range rise can look smaller in someone carrying extra weight. Weight loss can raise the reading without anything going wrong.
• Major illness or surgery: serious illness and some major operations can suppress FSH, sometimes sharply, and the effect can persist for days to weeks. Wait until you have recovered.
• Biotin supplements: high-dose biotin can throw off some lab assays in either direction. Stop it for at least 72 hours before the draw. Rarely, certain antibodies in the blood produce a falsely high result that disagrees across platforms.

What to Do With an Out-of-Pattern Result

Don't act on FSH alone. Pair it with estradiol in women, and with testosterone and LH in men, because the pattern is the diagnosis. A high FSH with low estradiol before age 40 points to primary ovarian insufficiency. Confirm it, then look for causes with chromosome testing, FMR1 premutation testing, and autoimmune testing when appropriate. If primary ovarian insufficiency is confirmed, physiologic hormone replacement is usually the treatment until the average age of natural menopause unless there is a reason not to use it; bone density and heart-risk checks matter too. A low FSH with low estradiol sends the search upstream, toward the pituitary and hypothalamus, adding prolactin and thyroid testing and, when indicated, brain imaging.

In a man, a high FSH with low testosterone points to primary testicular failure and calls for a semen analysis and a urology referral. A high FSH with normal testosterone and a low sperm count can still point to sperm-production failure. When the question is egg reserve, AMH and an antral follicle count on ultrasound add what FSH cannot. Given how much FSH varies in premenopausal women, repeat before you make any irreversible decision, and bring in a reproductive endocrinologist when the pattern is unclear.